Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections

被引:95
作者
Kaul, Rupert
Nagelkerke, Nico J.
Kimani, Joshua
Ngugi, Elizabeth
Bwayo, Job J.
MacDonald, Kelly S.
Rebbaprgada, Anu
Fonck, Karolien
Temmerman, Marleen
Ronald, Allan R.
Moses, Stephen
机构
[1] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[2] Univ Nairobi, Nairobi, Kenya
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Mt Sinai Hosp, Dept Microbiol, Toronto, ON, Canada
[5] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[6] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada
[7] Univ Manitoba, Community Hlth Sci Med, Winnipeg, MB, Canada
[8] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates
[9] Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reproduct Hlth, Ghent, Belgium
基金
加拿大健康研究院;
关键词
D O I
10.1086/522006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Prevalent herpes simplex virus type 2 (HSV- 2) infection increases human immunodeficiency virus acquisition. We hypothesized that HSV-2 infection might also predispose individuals to acquire other common sexually transmitted infections (STIs). Methods. We studied the association between prevalent HSV-2 infection and STI incidence in a prospective, randomized trial of periodic STI therapy among Kenyan female sex workers. Participants were screened monthly for infection with Neisseria gonorrhoeae and Chlamydia trachomatis, and at least every 6 months for bacterial vaginosis (BV) and infection with Treponema pallidum, Trichomonas vaginalis, and/or HSV-2. Results. Increased prevalence of HSV-2 infection and increased prevalence of BV were each associated with the other; the direction of causality could not be determined. After stratifying for sexual risk-taking, BV status, and antibiotic use, prevalent HSV-2 infection remained associated with an increased incidence of infection with N. gonorrhoeae (incidence rate ratio [IRR], 4.3 [95% confidence interval {CI}, 1.5-12.2]), T. vaginalis (IRR, 2.3 [95% CI, 1.3-4.2]), and syphilis (IRR, 4.7 [95% CI, 1.1-19.9]). BV was associated with increased rates of infection with C. trachomatis (IRR, 2.1 [95% CI, 1.1-3.8]) and T. vaginalis (IRR, 8.0 [95% CI, 3.2-19.8]). Conclusion. Increased prevalences of HSV-2 infection and BV were associated with each other and also associated with enhanced susceptibility to an overlapping spectrum of other STIs. Demonstration of causality will require clinical trials that suppress HSV-2 infection, BV, or both.
引用
收藏
页码:1692 / 1697
页数:6
相关论文
共 25 条
[11]   Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: A randomized controlled trial [J].
Kaul, R ;
Kimani, J ;
Nagelkerke, NJ ;
Fonck, K ;
Ngugi, EN ;
Keli, F ;
MacDonald, KS ;
Maclean, IW ;
Bwayo, JJ ;
Temmerman, M ;
Ronald, AR ;
Moses, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (21) :2555-2562
[12]  
Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009
[13]   Risk factors for genital ulcerations in Kenyan sex workers - The role of human immunodeficiency virus type I infection [J].
Kaul, R ;
Kimani, J ;
Nagelkerke, NJD ;
Plummer, FA ;
Bwayo, JJ ;
Brunham, RC ;
Ngugi, EN ;
Ronald, A .
SEXUALLY TRANSMITTED DISEASES, 1997, 24 (07) :387-392
[14]   ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY HERPESVIRUS-INFECTION - IDENTIFICATION OF A REGION WITHIN THE LONG TERMINAL REPEAT THAT RESPONDS TO A TRANS-ACTING FACTOR ENCODED BY HERPES-SIMPLEX VIRUS-1 [J].
MOSCA, JD ;
BEDNARIK, DP ;
RAJ, NBK ;
ROSEN, CA ;
SODROSKI, JG ;
HASELTINE, WA ;
HAYWARD, GS ;
PITHA, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7408-7412
[15]   Pathogenic Neisseria trigger expression of their carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1; previously CD66a) receptor on primary endothelial cells by activating the immediate early response transcription factor, nuclear factor-κB [J].
Muenzner, P ;
Naumann, M ;
Meyer, TF ;
Gray-Owen, SD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :24331-24340
[16]   Changing trends in genital herpes simplex virus infection in Bergen, Norway [J].
Nilsen, A ;
Myrmel, H .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (08) :693-696
[17]   Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial [J].
Ouedraogo, Abdoulaye ;
Nagot, Nicolas ;
Vergne, Laurence ;
Konate, Issouf ;
Weiss, Helen A. ;
Defer, Marie-Christine ;
Foulongne, Vincent ;
Sanon, Anselme ;
Andonaba, Jean-Baptiste ;
Segondy, Michel ;
Mayaud, Philippe ;
Van de Perre, Philippe .
AIDS, 2006, 20 (18) :2305-2313
[18]   Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract [J].
Rebbapragada, Anuradha ;
Wachihi, Charles ;
Pettengell, Christopher ;
Sunderji, Sherzana ;
Huibner, Sanja ;
Jaoko, Walter ;
Ball, Blake ;
Fowke, Keith ;
Mazzulli, Tony ;
Plummer, Francis A. ;
Kau, Rupert .
AIDS, 2007, 21 (05) :589-598
[19]   A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis [J].
Schwebke, J. R. ;
Desmond, R. A. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :213-219
[20]   How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis? [J].
Wald, A ;
Corey, L .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1509-1512